Addition of Inflammatory Biomarkers Did Not Improve Diabetes Prediction in the Community: The Framingham Heart Study — Dhayana Dallmeier (2012) | RDL Network
Addition of Inflammatory Biomarkers Did Not Improve Diabetes Prediction in the Community: The Framingham Heart Study
Article 2012 en
Authors
DD
Dhayana Dallmeier
ML
Martin G. Larson
NW
Na Wang
Abstract
1 min read
Biomarkers representing different inflammatory pathways are associated with incident diabetes but do not remain statistically significant after adjustment for established clinical covariates. Inflammatory biomarkers might not be an effective resource to predict type 2 diabetes in community-based samples. (J Am Heart Assoc. 2012;1:e000737 doi: 10.1161/JAHA.112.000869.).
Robert Araujo Contreras, Adlin Pinheiro, Matthew Kang, Joseph Sisto, Oluchi Ekenze, Hugo J. Aparicio, Alexa Beiser, Jayandra J. Himali, Vasileios Lioutas, Emelia Benjamin, Charles DeCarli, Sudha Seshadri, Serkalem Demissie, José R. Romero
Debora Melo van Lent, Hannah Gokingco, Emelia Benjamin, Ramachandran S. Vasan, Paul F. Jacques, Alexa S. Beiser, Sudha Seshadri, Mini E. Jacob, Jayandra J. Himali
Leah E. Cahill, Allie S. Carew, Rania A. Mekary, Kenneth J. Mukamal, Eric B. Rimm, Kerry L. Ivey, Susan Krikland, Olga Theou, Chris M. Blanchard, Ratika Parkash, Robin Urquhart, Ferhan Siddiqi, Mark Bennett, Frank B Hu
Discussion(0)
No comments yet. Be the first to comment.